Pharmaceuticals and Biotech

Showing 11-20 of 41

23 Dec 2020  |  North America

I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market

Upcoming Product Launches in Adoptive Cell Therapy Segment Hold Future Growth Potential

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

USD 4,950.00
17 Dec 2019  |  Global

Emerging Microbiome Technologies for Applications in Skin Care

Microbiome-based Innovations Transforming the Personal Care Landscape

Skin microbiome industry has been rapidly evolving since the past few years and is likely to witness new innovations in the near future. Apart from emerging new start-ups in this area, several leading cosmetic and industry participants are likely to shift focus towards emerging microbiome-based beauty platforms.As the consumer focuses towards the...

USD 4,950.00

USD 4,455.00 save 10 %

27 Nov 2019  |  North America

Global Contract Research Organization (CRO) Market, Forecast to 2024

Increased Technology Adoption in the Form of eClinical Solutions and Innovative Trial Designs is Expected to Transform the CRO Landscape

Increased technology adoption in the form of eClinical solutions and innovative trial designs is expected to transform the CRO landscape. Owing to a constantly changing pharmaceutical landscape, the industry is expected to witness a moderate 4% to 5% growth in the next 5 to 7 years, to surpass $1.5 trillion by 2025. In coordination with the indust...

USD 4,950.00

USD 4,455.00 save 10 %

02 Dec 2019  |  North America

Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO), Forecast to 2024

Advancements in Continuous Manufacturing Technology, Necessary to Meet New Demand in the Orphan Drugs Segment and Personalized Medicine, Will Give a New Growth Vector to CMOs

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...

USD 4,950.00

USD 4,455.00 save 10 %

25 Apr 2019  |  North America

Growth Opportunities in Global Vaccines Market, Forecast to 2024

Increased Investment in Adult Immunization and Improved Mammalian Cell-culture Expression Systems will Drive Growth and Profitability

The report provides an overview of the global vaccine market estimating the market size broken down by different segments. Vaccines, though a sub-set of biologics, have a completely different dynamic. Not only are they largely designed for a healthy cohort but are also exponentially influenced by government actions and policies. While old generatio...

USD 4,950.00

USD 4,207.50 save 15 %

30 Apr 2019  |  Global

Technological Advances Enabling Stem Cells Reprogramming

Technologies Paving New Avenues to Drive Breakthrough Research Toward the Discovery of Next Generation Therapeutics

Since the advent of stem cells reprogramming after the discovery of the differentiation factors that allow the creation of human induced pluripotent stem cells, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells. Indeed, there is an increasing demand for the more efficient product...

USD 4,950.00

USD 4,207.50 save 15 %

25 Jun 2019  |  Global

Technologies Transforming the Biomanufacturing Landscape

Translating Technology Innovation to Market Competitiveness

Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...

USD 4,950.00

USD 4,207.50 save 15 %

27 Aug 2019  |  North America

Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024

Digital Solutions will Spark Integrated Development Approaches and Successful Adjunctive Therapies for Disease Modification

As one lives longer, one needs to increasingly battle age-related disorders. Neurodegenerative disorders are the most worrisome, because they impact millions of people around the world and lack any curative therapy. While companies continue their search, they are also battling declining revenues from marketed products used to manage symptoms. Heavy...

USD 4,950.00

USD 4,207.50 save 15 %

20 Sep 2019  |  Global

Technological Advances in Biobetter and Biosimilar Platforms

Therapeutic Outcomes Optimization

Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need. Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases. In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer per...

USD 4,950.00

USD 4,207.50 save 15 %

23 Aug 2019  |  South Asia, Middle East & North Africa

Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020

Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...

USD 4,950.00

USD 4,207.50 save 15 %

Showing 11-20 of 41